Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 25Thoracic 11Gastrointestinal 10Lymphoid 8Gynecologic 8CNS 8Head & Neck 7Other solid neoplasm 6Genitourinary 5Other hematologic neoplasm 4Tumor-Agnostic 3Dermatologic 3Sarcoma 2

Conditions

Melanoma 2Skin Neoplasms 1Neoplasm Metastasis 1Carcinoma, Basal Cell 1Basal Cell Nevus Syndrome 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 195aldesleukin 148Interleukin-2 110fludarabine phosphate 107trametinib 85Temozolomide 83fludarabine 81Dacarbazine 81dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Magnetic Resonance Spectroscopy 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Aminolevulinic Acid 49binimetinib 48Specimen Handling 48Carboplatin 48Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NVP-BKM120 × Dermatologic × Clear all
NCT02159066 2024-03-05

LOGIC-2

Pfizer

Phase 2 Completed
158 enrolled 40 charts
Dermatologic

Melanoma

NCT02303041 2019-01-29

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

Stanford University

Phase 2 Terminated
10 enrolled 11 charts
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Skin Neoplasms

NCT02452294 2017-05-03

BUMPER

University Hospital Tuebingen

Phase 2 Unknown
22 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡